Skip to main content

Is still effective massive allograft reconstruction in parosteal osteosarcoma of the distal femur? Review of the literature and advantages of newer technologies

Abstract

Purpose

Parosteal Osteosarcoma is a well-differentiated, low-grade bone sarcoma. It most commonly occurs in the third decade of life, usually in the distal femur. This study aims to perform a literature review about the types of reconstructions reported and to analyze the results of an updated technique of resection using custom-made 3D-printed cutting guides.

Methods

We perform a systematic literature review about parosteal osteosarcoma, evaluating treatments, margins, local recurrence, complications, and functional results when available. We also report a case treated in our Center with a revisited technique introducing custom-made 3D-printed cutting guides.

Results

We analyzed 12 studies with a total of 151 patients. The distal femur was the most frequently reported site (81.5%). After distal femur resection, reconstruction was performed with graft in most cases (48%), followed by prosthetic reconstruction (40%). Margins were wide in 85.5% of cases. The total incidence of local recurrence was 11%. Functional results were excellent in all cases, with a mean MSTS score of 86%. In our case, with the help of the jigs, the surgical technique was relatively easy, graft fusion excellent and fast, margins wide, and functional results excellent.

Conclusions

In the literature, the most commonly used type of reconstruction after resection is biological with graft. Indeed, despite the increasing number of prosthetic reconstructions, the historical diaphysometaphyseal hemiresection and graft is still indicated in parosteal osteosarcoma of the distal femur. New technologies, such as the jigs we used, allow significant advantages during the procedure: reduce the resection and graft preparation time, allow a better match between components, and help to obtain safer margins, sparing as much bone as possible.

Introduction

The first report on parosteal osteosarcoma was in 1951 by Geschicter and Copeland, who considered it a benign tumor of the surface called Parosteal Osteoma [1]. Thanks to numerous subsequent studies, it became clear that it was instead a low-grade malignant bone tumor and was officially defined as Parosteal Osteosarcoma (PO).

PO represents an uncommon malignant bone tumor, accounting for approximately 1% of primary bone tumors and 4% of all osteosarcomas [2]. It is a slow-growing malignant tumor with a female predominance (60%) and occurs in the third decade of life, thus in patients older than the median age of conventional osteosarcomas [3].

It usually arises from the bone cortical surface over the metaphyseal region. In 70% of cases, it is located at the posterior surface of the distal femur, followed by the proximal tibia and proximal humerus [4].

The clinical manifestation is represented by a painless mass lasting for an extended period, with a decreased range of movement of the adjacent joint. Dull pain and local tenderness are the second most common symptoms.

The tumor usually manifests on the X-rays as a lobulated mass protruding from the underlying cortex with a broad base attachment. It has an irregular pattern of mineralization, and its center is usually more radiodense than the periphery [4]. The extension into the medullary are better demonstrated by computed tomography and magnetic resonance imaging, which has been seen in 22% to 58% of patients. [6]

A characteristic cleavage between the tumor and the cortex can be seen in up to 65% of cases. The underlying bone cortex may be thickened or partially eroded, and the periosteal reaction is generally absent [6].

The treatment of PO is exclusively represented by surgery with wide-margin resection and reconstruction; chemotherapy and radiotherapy are not options to be considered.

Historically, the surgical approach was represented by the posterior diaphysometaphyseal hemiresection, according to Campanacci [7] but several types of reconstruction methods are still used in different countries: the most widely used is biological reconstruction with graft and screws; reconstruction with grafts and plates is also sometimes described; many cases of PO are also treated with segmental resection and reconstruction with a modular prosthesis [7,8,9,10].

This study aims to perform a literature review on the different surgical techniques for reconstructing the distal femur after resection of parosteal osteosarcoma to evaluate if the graft is still indicated and to describe how the newer technologies can improve the results.

Material and methods

A systematic literature review was performed using PubMed and Google Scholar research libraries. The search terms used in combination were "parosteal osteosarcoma" and "distal femur." All manuscripts with full-text availability in English literature, published between 1990 and 2022, were analyzed. Exclusion criteria were: lack of complete information with only the abstract available, papers not reporting parosteal osteosarcoma, and papers reporting only parosteal osteosarcoma in sites different from the distal femur.

Two reviewers (JC, EP) independently double-screened all records to assess the manuscripts included in the study; a third reviewer (GT) checked all excluded records and resolved discrepancies.

The data extracted from the selected studies included treatments, margins, local recurrence, complications, and functional results when available.

We also reported a patient with distal femur PO treated in our Center by revisiting posterior diaphysometaphyseal hemiresection of the distal femur and reconstruction with a bone graft using custom-made 3D printed cutting guides.

The research has been performed under the Declaration of Helsinki. The patient gave written informed consent to be included in scientific studies upon admission to the hospital, and our Institutional Ethical Board Approval was obtained.

Case report

We treated a 15-year-old boy with left distal femur PO. The radiological characteristics, the patient's symptoms, and the location of the lesion were pathognomonic for parosteal osteosarcoma, and there was no need for a biopsy to confirm the diagnosis (Fig. 1).

Fig. 1
figure 1

A, B Antero-Posterior and Lateral X-rays of the left knee show a lobulated, radiodense lesion protruding over the posterior cortex of the distal femur. It attaches to the underlying cortex with no invasion into the medullary bone. C, D: MRI: sagittal and axial scan of a T1-weighted image of the left distal femur of the patient. A protruding mass, with low signal intensity, arising from the posterior cortical of the femur can be seen. The medullary canal and the cruciate ligaments are not involved

In the majority of radiologically typical case of evident low-grade lesions, biopsy can be omitted. Doubtful lesions should undergo biopsy to identify high-grade or dedifferentiated tumors [9, 20].

Historically, the surgical treatment for PO was the posterior diaphysometaphyseal hemiresection and reconstruction with bone graft, as reported by Campanacci et al. in 1984 [14].

This technique requires a double incision (one medial and one lateral) at the distal third of the thigh, prolonged beyond the joint spacing. The gastrocnemius and adductor major muscles are dissected 1–2 cm from their femoral insertion. The two surgical accesses can be joined to have an adequate view of the mass to be resected and a reasonable control of popliteal vessels and nerves [7].

We have reviewed the classic tumor resection and femoral reconstruction technique by introducing 3D-printed cutting guides for osteotomies.

3D printing is an additive manufacturing technique that allows to transform a digital model into a three-dimensional object. Three-dimensional models are obtained by processing digital radiological studies of patients, such as computed tomography (CT) scans, and when the virtual model has been obtained, it can be printed.

The planning was carried out with the collaboration of a team of engineers. First, a thin-layer (1 mm) CT scan of the host and graft distal femurs was performed (Fig. 2).

Fig. 2
figure 2

Resection planes based on CT scan. The coronal resection plane is posterior; the superior plane is tilted (40°), and the inferior plane is tilted (40°), aiming to preserve the posterior condyle

The images were then acquired in DICOM format (digital imaging and communications in medicine) and transferred to a specific reconstruction software (ProMade® platform, Lima Corporate, San Daniele del Friuli, Udine, Italy). The guides are in polyamide. These arrived non sterile and were stored at 0–50° in their protective closed packaging.

Based on these, the cutting planes for the patient and the graft are virtually established to obtain adequate wide margins (about 1 cm to each site except 0.8 cm in the distal part because we don’t have enough space), preserving the residual bone and trying to facilitate the reconstruction (Fig. 3).

Fig. 3
figure 3

The resection jigs were one lateral and one medial, with the possibility of being connected and stabilized to the bone by pins. They allow following a precise and regular cut, previously planned on the CT scan. The jigs made for the native bone (A) and for the graft B are produced by the same system. This jigs for the graft perfectly fitted with the graft and have the same cutting line of the host bone

Two weeks after the approval of the guide's design, these jigs and two phantom models of the femurs were sent to our Center.

According to the standard technique a double incision is required at the distal third of the thigh, prolonged beyond the joint spacing.

After isolating the muscles and the neuro-vascular bundle, the two lateral and medial surgical accesses can be joined, in order to have an adequate view of the mass to be resected and a good control on popliteal vessels and nerves. At this point we put the medial and lateral jigs on the femur and we cut the bone with a saw inserted in the hole of the jigs.

After the tumor resection we prepare the graft with the dedicated cutting guides.

The final reconstruction was performed by fixing the graft with six self-tapping cortex screws (4.5 mm) in the diaphysis part and three self-drilling cancellous bone screws (4.5 mm) in the epiphyseal part, all with a postero-anterior course: half of these with a medial to lateral direction and the other half with the opposite direction (Fig. 4).

Fig. 4
figure 4

Antero-Posterior and Lateral A, B postoperative radiographs

The whole process lasted almost 5 h due to a considerable shortening of the preparation time of the bone graft: tumor and graft resections lasted about 30 min thanks to cutting guides.

Definitive histology confirmed the diagnosis and reported wide margins.

Immediately after the surgery, the patient showed a nerve palsy in the territory of the Common Peroneal Nerve, with the impossibility of dorsiflexing the toes and the right foot and a related sensitivity deficit. He was immediately treated with neurotropic supplements and electrostimulation of the muscles involved with progressive improvement of sensibility and movement.

After the surgery, weight-bearing was not allowed on the affected limb for two months; a brace to keep the knee full extension was used during the first month and then removed, allowing free knee mobilization, and then a rehabilitation procedure was set up to recover the knee's full range of motion.

After two months, the first signs of bone integration of the graft could already be detected by X-ray evaluation; a progressive load was also granted until complete weight-bearing in six months.

A three-month follow-up was set, with X-rays of the left knee and chest and knee CT scans with subtraction of artifacts.

After nine months, the X-rays showed that the graft was almost wholly fused to the patient's bone.

At the last follow-up, 18 months after surgery, the X-rays showed the graft perfectly integrated, without signs of mobilization or recurrence. The patient walked without aids with full weight-bearing on the treated limb; the knee range of motion is complete in extension with a slight deficit in flexion of about 10°. The patient also regained the sensitivity at the level of the territory of the Common Peroneal Nerve with complete extension of the toes, even against resistance. Functional results were excellent, with an MSTS score of 30. (Fig. 5).

Fig. 5
figure 5

A, B: Antero-Posterior and Lateral X-rays at 3 months; C, D: Antero-Posterior and Lateral X-rays after 9 months: the graft is almost completely fused to the host bone; E, F: Antero-Posterior and Lateral X-rays at 12 months: the graft is perfectly integrated; G, H: CT scan at 18 months, the graft is perfectly integrated

Results

The research strategy returned 12 studies with a total of 151 patients affected by PO. The distal femur was the most frequently reported site (81.5%), followed by the proximal humerus (9 cases, 6.2%), the proximal tibia (4 cases, 2.75%), and the proximal femur (4 cases, 2.75%). The mean age of patients in all sites was 29 years old (range 25–31 years old). The mean follow-up of patients was 6.7 years (range 2.8–8.5 years) (Table 1).

Table 1 Systematic literature review about parosteal osteosarcoma in all sites between 1990 and 2022

After excluding different sites, 123 distal femur PO were analyzed. (Table 2).

Table 2 Systematic literature review about distal femur parosteal osteosarcoma between 1990 and 2022

The surgical treatment was resection of the posterior cortex of the distal femur and reconstruction with graft (26 autografts and 33 allografts) in half of cases (59/117 cases, 50%). The second most frequent type of surgery was distal femur resection and prosthetic reconstruction (47/117, 40%). Unexpectedly, 7 cases of amputation or rotationplasty and 4 knee arthrodesis were reported, especially in older cases with more complex management. (Table 2).

Margins were wide in 85.5% of reported cases (77/90 cases) independently from the types of surgery. (Table 2).

The total incidence of local recurrence was 11.4% (14/123 cases), but it was impossible to determine if there was a correlation with the types of surgery or margins obtained. (Table 2).

Functional results, evaluated with the MSTS score, were described in 7/12 papers; overall functional results were excellent in all cases, with a mean score of 85.9% (Table 2).

Discussion

Parosteal osteosarcoma arises from the metaphyseal region over the cortical bone surface: in 80% of cases, in the posterior surface of the distal femur, followed by the proximal humerus and proximal tibia [1,2,3].

Wide margins surgery is the only treatment for this type of osteosarcoma, with survival up to 90% at 5 years [9, 11, 15]. Local recurrence may occur when wide resection is inadequate or in the case of dedifferentiation [12, 13].

Local recurrence was highly related from extent of resection with an incidence of 8–88% [9]. The incidence of metastatic disease range from 1 to 22% and was mostly related to dedifferentiation, but not to medullary involvement [9].

Historically, the treatment of PO in the distal femur was the posterior diaphysometaphyseal hemiresection, according to Campanacci; however, several reconstructions are still used [7,8,9,10].

Treatment choice is based on local extension, proximity to neurovascular structures, joint invasion, and extent of medullary involvement [9].

The influence of medullary involvement on survival is debated; some authors reported that the invasion into the medullary canal was a sign of tumor aggressiveness and local recurrence, but other authors have found no connection between medullary involvement and aggressiveness [14, 15].

Funovics et al. [9] and Liu et al. [12] compared biologic and prosthetic reconstruction after the resection of 28 PO in all sites, concluding that there is no difference between these two types of surgery in terms of local recurrence, metastases, or functional results; although they reported a higher incidence of revisions after prosthetic reconstructions.

Other authors reported satisfactory oncologic and functional outcomes without complications using the classic hemicortical resection technique with a 100% fusion rate of the allograft within 30 months postoperatively [12, 16,17,18,19].

The most common complication is host bone fracture, followed by local recurrence, nonunion, and infection. Rarely allograft fractures can occur. These complications are related to the size of the bone defect and often require surgical reintervention [14].

The incidence of nonunion for intercalary reconstructions with an allograft have been cited about 30% and fracture about 18% [17, 18].

Using the jigs, it is possible to spare more bone of the patients and make more accurate cuts; these allowed to reduce the nonunion and fracture rate. For these reasons, with the use of the jigs, theoretically, a plate is not needed as first step because the risk of fracture is lower.

Considering the good functional results and fast recovery to normal activities with prosthetic reconstructions, are biological reconstructions still indicated in these cases?

This literature review confirmed that the most widely used type of reconstruction remains the biological reconstruction with graft (47.9%), equally distributed between autologous grafts or allografts. In 40% of cases, distal femur resection and prosthetic reconstruction were reported. The only contraindication the hemiresection is the medullary canal involvement.

To improve the matching between the host bone and the graft and consequently the fusion of the graft, newer techniques with 3D printing technology can significantly influence the surgery.

In recent years, the techniques of designing and manufacturing surgical guides have been improved, as well as the printing material. With the rapid emergence of 3D printing technology, surgeons have started to apply this in nearly all areas of orthopedic surgery [23]. The orthopedic field that has benefited most from the development of 3D technologies is undoubtedly the oncology one [24, 25].

In 2021, Wu conducted a technical report of hemicortical bone tumor resection in the distal femur using a 3D printing guide plate for low-grade bone sarcomas [25]. In that study were used inactivated autologous bone grafts and reimplanted with plates and screws. This technology allowed surgeons to achieve negative resection margins more easily and safely, reducing surgical time and sparing important anatomic structures, leading to significant functional and reconstructive advantages for the patient [25,26,27].

We reported a case treated with the posterior diaphysometaphyseal hemiresection and reconstruction with allograft with custom jigs to guide both host and graft osteotomies. First, cutting guides allowed us to prepare the graft in a few minutes more safely and accurately, reducing the fracture risk, which could compromise the surgical procedure.

Second, through this procedure, we obtained a remarkable graft fitting to the host bone: only a minimal discrepancy remained at the level of the condyles due to minimal different anatomies. This fitting resulted in a considerable contact area, facilitating the integration.

Currently, the use of 3D cutting procedures has two types of limitations: time and cost. The time required to develop and produce all the projects is currently about three to four weeks and should be further reduced in order to be able to develop a similar plan even in cases of much more aggressive sarcomas. The cost to produce 3D printed cutting guides is company and material dependent and may be variable in different countries.

In conclusion, in patients with PO, the classic posterior distal femur diaphysometaphyseal hemiresection and reconstruction with allograft is still indicated due to the low grade of the tumor, the young age of the patients, good functional results, and lower incidence of complication than prosthetic reconstructions. The 3D-printed cutting guides have many advantages: precise cuts permit a reduction of surgical time, improving accuracy of negative surgical margins, sparing healthy tissue, and reducing the risk of graft breakage during preparation. In the same time, they lead to a better fit between graft and host bones with a consequent reduction in the integration time.

Availability of data and materials

Information about clinical, imaging and histological details were found in the clinical chart of the patient of patients were contacted by phone.

References

  1. Geschickter CF, Copeland MM. Parosteal osteoma of bone: a new entity. Ann Surg. 1951;133(6):790–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Raymond AK. Surface osteosarcoma. ClinOrthop Relat Res 1991;140–8.

  3. Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK. Parosteal osteosarcoma: a clinicopathological study. J Bone Joint Surg Am. 1994;76(3):366–78.

    Article  CAS  PubMed  Google Scholar 

  4. Hang JF, Chen PC. Parosteal osteosarcoma. Arch Pathol Lab Med. 2014;138(5):694–9. https://doi.org/10.5858/arpa.2013-0030-RS.Review. (PMID: 24786129).

    Article  PubMed  Google Scholar 

  5. Han I, Oh JH, Na YG, Moon KC, Kim HS. Clinical outcome of parosteal osteosarcoma. J Surg Oncol. 2008;97(2):146–9. https://doi.org/10.1002/jso.20902.

    Article  PubMed  Google Scholar 

  6. Jelinek JS, Murphey MD, Kransdorf MJ, Shmookler BM, Malawer MM, Hur RC. Parosteal osteosarcoma: value of MR imaging and CT in the prediction of histologic grade. Radiology. 1996;201(3):837–42.

    Article  CAS  PubMed  Google Scholar 

  7. Capanna R, Ruggieri P, Biagini R, Campanacci M. Posterior diaphyso-metaphyseal hemiresection of the femur. Chir Organi Mov. 1984;69(1):91–6.

    CAS  PubMed  Google Scholar 

  8. Prabowo Y, Kamal AF, Kodrat E, Prasetyo M, Maruanaya S, Efar TS. Parosteal osteosarcoma: a benign-looking Tumour, amenable to a variety of surgical reconstruction. Int J Surg Oncol. 2020;2020(1):4807612. https://doi.org/10.1155/2020/4807612.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Funovics PT, Bucher F, Toma CD, Kotz RI, Dominkus M. Treatment and outcome of parosteal osteosarcoma: Biological versus endoprosthetic reconstruction. J Surg Oncol. 2011;103(8):782–9. https://doi.org/10.1002/jso.21859.

    Article  PubMed  Google Scholar 

  10. Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Nishida H, Takeuchi A, Kimura H, Miwa S, Inatani H, Okamoto H, Yamada S, Ikeda H, Sawada-Kitamura S, Nojima T, Ooi A, Otsuka T. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases. Int J Clin Oncol. 2014;19(4):731–8. https://doi.org/10.1007/s10147-013-0592-z.

    Article  PubMed  Google Scholar 

  11. Okada K, Unni KK, Swee RG, Sim FH. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer. 1999;85(5):1044–54.

    Article  CAS  PubMed  Google Scholar 

  12. Sheth DS, Yasko AW, Raymond AK, Ayala AG, Carrasco CH, Benjamin RS, Jaffe N, Murray JA. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer. 1996;78(10):2136–45.

    Article  CAS  PubMed  Google Scholar 

  13. Johnson K, Davies AM, Evans N, Grimer RJ. Imaging recurrent parosteal osteosarcoma. Eur Radiol. 2001;11(3):460–6. https://doi.org/10.1007/s003300000673.

    Article  CAS  PubMed  Google Scholar 

  14. Campanacci M, Picci P, Gherlinzoni F, Guerra A, Bertoni F, Neff JR. Parosteal osteosarcoma. J Bone Joint Surg Br. 1984;66(3):313–21. https://doi.org/10.1302/0301-620X.66B3.6586725.

    Article  CAS  PubMed  Google Scholar 

  15. Liu T, Liu ZY, Zhang Q, Zhang XS. Hemicortical resection and reconstruction using pasteurised autograft for parosteal osteosarcoma of the distal femur. Bone Joint J. 2013;95:1275–9. https://doi.org/10.1302/0301-620X.95B9.31433.

    Article  PubMed  Google Scholar 

  16. Lewis VO, Gebhardt MC, Springfield DS. Parosteal osteosarcoma of the posterior aspect of the distal part of the femur. Oncological and functional results following a new resection technique. J Bone Joint Surg Am. 2000;82(8):1083–8. https://doi.org/10.2106/00004623-200008000-00003.

    Article  CAS  PubMed  Google Scholar 

  17. Deijkers RL, Bloem RM, Hogendoorn PC, Verlaan JJ, Kroon HM, Taminiau AH. Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours. J Bone Joint Surg Br. 2002;84(7):1009–14. https://doi.org/10.1302/0301-620x.84b7.13032.

    Article  CAS  PubMed  Google Scholar 

  18. Agarwal M, Puri A, Anchan C, Shah M, Jambhekar N. Hemicortical excision for low-grade selected surface sarcomas of bone. Clin Orthop Relat Res. 2007;459:161–6. https://doi.org/10.1097/BLO.0b013e318059b8eb.

    Article  PubMed  Google Scholar 

  19. Savvidou OD, Goumenos S, Trikoupis I, Kaspiris A, Melissaridou D, Gavriil P, Georgoulis J, Papagelopoulos PJ. Oncological and functional outcomes after hemicortical resection and biological reconstruction using allograft for parosteal osteosarcoma of the distal femur. Sarcoma. 2022;2022:5153924. https://doi.org/10.1155/2022/5153924.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kavanagh TG, Cannon SR, Pringle J, Stoker DJ, Kemp HB. Parosteal osteosarcoma. Treatment by wide resection and prosthetic replacement. J Bone Joint Surg Br. 1990;72(6):959–65. https://doi.org/10.1302/0301-620X.72B6.2246298.

    Article  CAS  PubMed  Google Scholar 

  21. Hoshi M, Matsumoto S, Manabe J, Tanizawa T, Shigemitsu T, Izawa N, Shi X, Kawaguchi N. Oncologic outcome of parosteal osteosarcoma. Int J Clin Oncol. 2006;11(2):120–6. https://doi.org/10.1007/s10147-005-0545-2.

    Article  PubMed  Google Scholar 

  22. Nouri H, Ben Maitigue M, Abid L, Nouri N, Abdelkader A, Bouaziz M, Mestiri M. Surface osteosarcoma: clinical features and therapeutic implications. J Bone Oncol. 2015;4(4):115–23. https://doi.org/10.1016/j.jbo.2015.07.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wilke BK, Cooper AR, Gibbs CP, Scarborough MT, Spiguel AR. Long-term functional outcomes of distal femoral replacements compared to geographic resections for parosteal osteosarcomas of the distal femur. Iowa Orthop J. 2018;38:177–81.

    PubMed  PubMed Central  Google Scholar 

  24. Lal H, Patralekh MK. 3D printing and its applications in orthopaedic trauma: a technological marvel. J Clin Orthop Trauma. 2018;9(3):260–8. https://doi.org/10.1016/j.jcot.2018.07.022.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Angelini A, Trovarelli G, Berizzi A, Pala E, Breda A, Ruggieri P. Three-dimension-printed custom-made prosthetic reconstructions: from revision surgery to oncologic reconstructions. Int Orthop. 2019;43(1):123–32. https://doi.org/10.1007/s00264-018-4232-0.

    Article  PubMed  Google Scholar 

  26. Gouin F, Paul L, Odri GA, Cartiaux O. Computer-assisted planning and patient-specific instruments for bone tumor resection within the pelvis: a series of 11 patients. Sarcoma. 2014;2014:1–9. https://doi.org/10.1155/2014/842709.

    Article  Google Scholar 

  27. Wu H, Yang S, Liu J, Li L, Luo Y, Dai Z, Wang X, Yao X, Zhou F, Li X. 3D printing guide plate for accurate hemicortical bone tumor resection in metaphysis of distal femoral: a technical note. J Orthop Surg Res. 2021;16(1):343. https://doi.org/10.1186/s13018-021-02374-w.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gkagkalis G, Moerenhout K, Rüdiger HA, Müller DA, Letovanec I, Cherix S. Pelvic chondrosarcoma treated by en bloc resection with patient-specific osteotomy guides and reimplantation of the extracorporeally irradiated bone as an osseocartilaginous structural orthotopic autograft: a report of two cases with description of the surgical technique. Case Rep Orthop. 2021;2(2021):5512143. https://doi.org/10.1155/2021/5512143.

    Article  Google Scholar 

  29. Gómez-Palomo JM, Estades-Rubio FJ, Meschian-Coretti S, Montañez-Heredia E, Santos-de De, la Fuente FJ. Internal Hemipelvectomy and reconstruction assisted by 3D printing technology using premade intraoperative cutting and placement guides in a patient with pelvic sarcoma: a case report. JBJS Case Connect. 2019;9(4):e0060. https://doi.org/10.2106/JBJS.CC.19.00060.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Open access funding provided by Università degli Studi di Padova. The Authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article.

Author information

Authors and Affiliations

Authors

Contributions

The manuscript has been read and approved by all the Authors. All authors contributed to: conception and design, acquisition of data, analysis and interpretation of data, drafting the article or revising it critically for important intellectual content, final approval of the version to be published, and agree to be accountable for all aspects of the work if questions arise related to its accuracy or integrity.

Corresponding author

Correspondence to Pietro Ruggieri.

Ethics declarations

Ethical approval

Each Author certifies that the research has been performed in accordance with the ethical standards in the 1964 Declaration of Helsinki. Each Author certifies that the patient and their relatives gave written informed consent to be included in scientific studies at hospital admission.

Consent for publication

This work has not been published previously, it is not under consideration for publication elsewhere, and, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.

Competing interests

Pietro Ruggieri is Consultant and Designer for Stryker and Exactech. Each Author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pala, E., Canapeti, J., Trovarelli, G. et al. Is still effective massive allograft reconstruction in parosteal osteosarcoma of the distal femur? Review of the literature and advantages of newer technologies. J Orthop Surg Res 19, 395 (2024). https://doi.org/10.1186/s13018-024-04880-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13018-024-04880-z